Fig. 10
From: Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight
Surface-modified/antigen labelled NPs for enhanced drug accumulation and target killing of intra-macrophagial amastigotes; [1] Attachment of Mannose labeled anti-leishmanial nano-DDS with Mannose-receptors on macrophage membrane, [2] Receptor mediated endocytosis of Mannosylated anti-leishmanial nano-DDS, [3] Release of entrapped drug, [4, 5] Effective intramacrophage parasitic killing by Mannosylated nano-DDS